<DOC>
	<DOCNO>NCT01032109</DOCNO>
	<brief_summary>The purpose study compare 12-month result two single initial treatments—photodynamic therapy verteporfin alone therapy combined intravitreal bevacizumab—for neovascular age-related macular degeneration , include patient polypoidal choroidal vasculopathy presume age-related macular degeneration .</brief_summary>
	<brief_title>Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>choroidal neovascularization cause agerelated macula degeneration previous treatment followup least 12 month baseline visual acuity range letter score 0 70 Early Treatment Diabetic Retinopathy Study chart choroidal neovascularization cause eye disease ocular surgery within past 3 mouth history uveitis intraocular pressure high 25 mmHg , glaucoma history systemic ocular thromboembolic event .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>